BR100 Increased By (0.71%)
BR30 Increased By (1.01%)
KSE100 Increased By (0.45%)
KSE30 Increased By (0.47%)
BECO 6.05 Increased By ▲ 0.28 (4.85%)
BML 53.25 Increased By ▲ 0.25 (0.47%)
BOP 34.35 Increased By ▲ 0.36 (1.06%)
CNERGY 8.19 Increased By ▲ 0.08 (0.99%)
DCL 12.20 No Change ▼ 0.00 (0%)
FCCL 53.66 Increased By ▲ 0.83 (1.57%)
FCSC 5.15 Increased By ▲ 0.08 (1.58%)
FFL 18.15 Increased By ▲ 0.20 (1.11%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 10.93 Increased By ▲ 0.05 (0.46%)
KEL 8.12 Increased By ▲ 0.10 (1.25%)
KOSM 5.37 Decreased By ▼ -0.15 (-2.72%)
MLCF 87.40 Increased By ▲ 0.89 (1.03%)
NBP 187.23 Increased By ▲ 2.07 (1.12%)
PACE 10.67 Increased By ▲ 0.09 (0.85%)
PAEL 39.90 Increased By ▲ 0.48 (1.22%)
PIAHCLA 26.30 Increased By ▲ 0.08 (0.31%)
PIBTL 17.50 Increased By ▲ 0.83 (4.98%)
PPL 229.58 Increased By ▲ 1.40 (0.61%)
PRL 34.80 Increased By ▲ 0.12 (0.35%)
PTC 67.07 Increased By ▲ 1.74 (2.66%)
SEARL 91.05 Increased By ▲ 0.92 (1.02%)
SSGC 27.08 Increased By ▲ 0.48 (1.8%)
TELE 8.60 Increased By ▲ 0.32 (3.86%)
THCCL 58.62 Increased By ▲ 0.12 (0.21%)
TPLP 8.58 Increased By ▲ 0.36 (4.38%)
TREET 24.65 Increased By ▲ 0.12 (0.49%)
TRG 70.35 Increased By ▲ 0.64 (0.92%)
WAVES 9.95 Increased By ▲ 0.01 (0.1%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)

The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan’s logistics capabilities.

According to a press statement released on Monday, the exemptions were approved following a comprehensive review by CCP’s Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations.

“These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors,” read the statement.

CCP grants six exemptions to pharma sector

CCP observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value.

Specific provisions within the shareholders’ agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure.

These approvals reaffirm CCP’s commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance, said CCP.

“All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market,” read the statement.

Comments

Comments are closed for this article.